{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:27:25Z","timestamp":1793618845370,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ebiom.2026.106531","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:52:22Z","timestamp":1792565542000},"page":"106531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-7898","authenticated-orcid":false,"given":"Jack E.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6883-666X","authenticated-orcid":false,"given":"Ciaran","family":"Gilbride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-1643","authenticated-orcid":false,"given":"Alex","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Dowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-6163","authenticated-orcid":false,"given":"Emma","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Findlay\u2013Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Al-Dainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khiyam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ruedas-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Salguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hewson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagida","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Belij-Rammerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ebiom.2026.106531_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41579-023-00871-9","article-title":"Crimean\u2013Congo haemorrhagic fever virus","volume":"21","author":"Hawman","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ebiom.2026.106531_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106531_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01069-24","article-title":"Promotion of order Bunyavirales to class Bunyaviricetes to accommodate a rapidly increasing number of related polyploviricotine viruses","volume":"98","author":"Kuhn","year":"2024","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004210","article-title":"Seroepidemiological studies of Crimean-Congo hemorrhagic fever virus in domestic and wild animals","volume":"10","author":"Spengler","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106531_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jinf.2022.09.007","article-title":"Risk factors for Crimean-Congo Haemorrhagic Fever (CCHF) virus exposure in farming communities in Uganda","volume":"85","author":"Atim","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106531_bib7","doi-asserted-by":"crossref","first-page":"387.e1","DOI":"10.1016\/j.cmi.2015.11.024","article-title":"Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study","volume":"22","author":"Leblebicioglu","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2026.106531_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coviro.2016.08.005","article-title":"Transmission and evolution of tick-borne viruses","volume":"21","author":"Brackney","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ebiom.2026.106531_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2017.05.010","article-title":"The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: a review of published field and laboratory studies","volume":"144","author":"Gargili","year":"2017","journal-title":"Antiviral Res"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106531_bib10","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3201\/eid2706.204643","article-title":"Retrospective identification of early autochthonous case of Crimean-Congo hemorrhagic fever, Spain, 2013","volume":"27","author":"Negredo","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3201\/eid1901.120299","article-title":"Seroprevalence of Crimean-Congo hemorrhagic fever virus, Bulgaria","volume":"19","author":"Christova","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106531_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2023.101198","article-title":"The raising threat of CCHF in Afghanistan: healthcare dilemmas and the need for comprehensive reponses","volume":"56","author":"Neyazi","year":"2024","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.ebiom.2026.106531_bib13","first-page":"14","article-title":"CCHFV vaccine development, current challenges, limitations, and future directions","author":"Ahata","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106531_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105698","article-title":"A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques","volume":"115","author":"Hawman","year":"2025","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41541-025-01164-3","article-title":"Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge","volume":"10","author":"Tipih","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2026.106531_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105017","article-title":"Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice","volume":"101","author":"Leventhal","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106531_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104188","article-title":"Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"82","author":"Leventhal","year":"2022","journal-title":"eBioMedicine"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106531_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02076-16","article-title":"Immunization with DNA plasmids coding for Crimean-Congo hemorrhagic fever virus capsid and envelope proteins and\/or virus-like particles induces protection and survival in challenged mice","volume":"91","author":"Hinkula","year":"2017","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106531_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156637","article-title":"Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses","volume":"11","author":"Dowall","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-021-00293-9","article-title":"A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice","volume":"6","author":"Suschak","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2026.106531_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104523","article-title":"Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model","volume":"90","author":"Saunders","year":"2023","journal-title":"eBioMedicine"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106531_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091516","article-title":"A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model","volume":"9","author":"Buttigieg","year":"2014","journal-title":"PLOS ONE"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106531_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2024.11.008","article-title":"Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes","volume":"188","author":"McFadden","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41541-023-00663-5","article-title":"GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus","volume":"8","author":"Scher","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106531_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection","volume":"5","author":"Golden","year":"2019","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106531_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v8040106","article-title":"Molecular insights into Crimean-Congo hemorrhagic fever virus","volume":"8","author":"Zivcec","year":"2016","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106531_bib27","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-016-2803-1","article-title":"Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system","volume":"161","author":"Suda","year":"2016","journal-title":"Arch Virol"},{"issue":"786","key":"10.1016\/j.ebiom.2026.106531_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adq5928","article-title":"Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread","volume":"17","author":"Pahmeier","year":"2025","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106531_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009973","article-title":"Immune responses in multiple hosts to nucleocapsid protein (NP) of Crimean-Congo hemorrhagic fever virus (CCHFV)","volume":"15","author":"Karaaslan","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib30","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41467-024-46110-4","article-title":"Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus","volume":"15","author":"Garrison","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106531_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/v14030544","article-title":"Mapping of antibody epitopes on the Crimean-Congo hemorrhagic fever virus nucleoprotein","volume":"14","author":"Lombe","year":"2022","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106531_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/v16101547","article-title":"The role of nucleocapsid protein (NP) in the immunology of Crimean-Congo hemorrhagic fever virus (CCHFV)","volume":"16","author":"Pirincal","year":"2024","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106531_bib33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S1473-3099(23)00351-1","article-title":"Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"23","author":"Leroux-Roels","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S2666-5247(21)00193-2","article-title":"Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial","volume":"3","author":"Bosaeed","year":"2022","journal-title":"Lancet Microbe"},{"issue":"10304","key":"10.1016\/j.ebiom.2026.106531_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(21)01699-8","article-title":"Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)","volume":"398","author":"Flaxman","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106531_bib36","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-5247(22)00126-4","article-title":"Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial","volume":"3","author":"Jenkin","year":"2022","journal-title":"Lancet Microbe"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41541-025-01212-y","article-title":"Nipah virus vaccines evaluated in pigs as a \u2018One Health\u2019 approach to protect public health","volume":"10","author":"McLean","year":"2025","journal-title":"npj Vaccines"},{"issue":"10269","key":"10.1016\/j.ebiom.2026.106531_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106531_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/microorganisms8050775","article-title":"The Crimean-Congo hemorrhagic fever virus NSm protein is dispensable for growth in vitro and disease in Ifnar(-\/-) mice","volume":"8","author":"Welch","year":"2020","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106531_bib40","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1089\/vbz.2011.0770","article-title":"Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus","volume":"12","author":"Atkinson","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.ebiom.2026.106531_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","article-title":"Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus","volume":"146","author":"Zivcec","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2026.106531_bib42","first-page":"13","article-title":"Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge","author":"Bian","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3390\/vaccines8010131","article-title":"Immunologic dose-response to adenovirus-vectored vaccines in animals and humans: a systematic review of dose-response studies of replication incompetent adenoviral vaccine vectors when given via an intramuscular or subcutaneous route","volume":"8","author":"Afrough","year":"2020","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106531_bib44","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106531_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v13061037","article-title":"Requirement of Fc-Fc gamma receptor interaction for antibody-based protection against emerging virus infections","volume":"13","author":"Keeler","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41541-024-00931-y","article-title":"Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice","volume":"9","author":"Karaaslan","year":"2024","journal-title":"npj Vaccines"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106531_bib48","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/21645515.2015.1078045","article-title":"A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease","volume":"12","author":"Dowall","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106531_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006628","article-title":"Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge","volume":"12","author":"Zivcec","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106531_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7030115","article-title":"Immunological analysis of a CCHFV mRNA vaccine candidate in mouse models","volume":"7","author":"Aligholipour Farzani","year":"2019","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106531_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006149","article-title":"Long-lived CD8+ T cell responses following Crimean-Congo haemorrhagic fever virus infection","volume":"11","author":"Goedhals","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106531_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01568-21","article-title":"Nucleoside-modified mRNA vaccines protect IFNAR(-\/-) mice against Crimean-Congo hemorrhagic fever virus infection","volume":"96","author":"Appelberg","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41541-024-00877-1","article-title":"Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus","volume":"9","author":"Sorvillo","year":"2024","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41541-025-01310-x","article-title":"A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection","volume":"10","author":"Rao","year":"2025","journal-title":"npj Vaccines"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106531_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ymthe.2022.09.016","article-title":"Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model","volume":"31","author":"Hawman","year":"2023","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib56","doi-asserted-by":"crossref","first-page":"9236","DOI":"10.1038\/s41467-024-53362-7","article-title":"Antibodies targeting the Crimean-Congo hemorrhagic fever virus nucleoprotein protect via TRIM21","volume":"15","author":"Leventhal","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106531_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2023.199173","article-title":"Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells","volume":"334","author":"Golden","year":"2023","journal-title":"Virus Res"},{"key":"10.1016\/j.ebiom.2026.106531_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106282","article-title":"CCHFV-M based DNA vaccine is highly immunogenic in multiple species and protects against challenge in cynomolgus macaques","volume":"243","author":"Suschak","year":"2025","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib59","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular stomatitis virus-based vaccine protects mice against Crimean-Congo hemorrhagic fever","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106531_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"Garrison","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106531_bib61","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo hemorrhagic fever virus subunit vaccines induce high levels of neutralizing antibodies but no protection in STAT1 knockout mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"Suppl 4","key":"10.1016\/j.ebiom.2026.106531_bib62","doi-asserted-by":"crossref","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","article-title":"Antibody response in Crimean-Congo hemorrhagic fever","volume":"11","author":"Shepherd","year":"1989","journal-title":"Rev Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106531_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114502","article-title":"Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38","volume":"43","author":"Shin","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2026.106531_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105244","article-title":"Immunobiology of Crimean-Congo hemorrhagic fever","volume":"199","author":"Rodriguez","year":"2022","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106531_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011948","article-title":"Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean\u2013Congo hemorrhagic fever virus","volume":"20","author":"Li","year":"2024","journal-title":"PLoS Pathog"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106531_bib66","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","article-title":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","volume":"184","author":"Fels","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106531_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100920","article-title":"Human antibody repertoire following Ebola virus infection and vaccination","volume":"23","author":"Fuentes","year":"2020","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106531_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106531_bib69","first-page":"14","article-title":"Impact of structural modifications of IgG antibodies on effector functions","author":"Damelang","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106531_bib70","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/icb.2016.65","article-title":"IgG subclass co-expression brings harmony to the quartet model of murine IgG function","volume":"94","author":"Collins","year":"2016","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106531_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191440","article-title":"Human antibody targeting Crimean-Congo hemorrhagic fever virus glycoprotein 38 protects mice against heterologous virus challenge","volume":"136","author":"Chapman","year":"2026","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib72","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41467-022-34923-0","article-title":"Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus","volume":"13","author":"Durie","year":"2022","journal-title":"Nat Commun"},{"issue":"6576","key":"10.1016\/j.ebiom.2026.106531_bib73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.abl6502","article-title":"Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies","volume":"375","author":"Mishra","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106531_bib74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.15212\/ZOONOSES-2022-0029","article-title":"In silico design of a Crimean-Congo hemorrhagic fever virus glycoprotein multi-epitope antigen for vaccine development","volume":"2","author":"Mears","year":"2022","journal-title":"Zoonoses"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426004159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426004159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:51:54Z","timestamp":1793616714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426004159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":74,"alternative-id":["S2352396426004159"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106531","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106531"}}